Ertapenem, a member of the carbapenem group of antibiotics, is a broad-spectrum antibiotic that is effective against multidrug-resistant gram-positive and gram-negative infections. In patients with acute or chronic kidney damage, one of the most serious side effects of ertapenem is neurotoxicity. Various clinical conditions such as seizures, hallucinations, delirium, confusion, and nystagmus may occur. Previous history of cerebral pathologies is a known risk factor for ertapenem-associated neurotoxicity. Immediate discontinuation of treatment is required. Although the symptoms usually resolve rapidly, cases with longer duration of symptoms have also been reported. Close monitoring of neurological status in such patients is essential.
References
1.
Deshayes S, Coquerel A, Verdon R. Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review. Drug Safety. 2017;40(12):1171–98.
2.
Hsaiky LM, Salinitri FD, Wong J, Jennings SLT, Desai NH, Lobkovich AM, et al. Pharmacokinetics and investigation of optimal dose ertapenem in intermittent hemodialysis patients. Nephrology Dialysis Transplantation. 2019;34(10):1766–72.
3.
Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL. Epileptogenic Potential of Carbapenem Agents: Mechanism of Action, Seizure Rates, and Clinical Considerations. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2011;31(4):408–23.
4.
Lee YC, Huang YJ, Hung MC, Hung SC, Hsiao CY, Cho HL, et al. Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control study. PLOS ONE. 12(7):e0182046.
5.
Molnar GP, Stephens KJ, George LV, Stewart JT. A Critical Interaction Between Ertapenem and Valproic Acid. Journal of Clinical Psychopharmacology. 2015;35(3):348–50.
6.
Fica AE, Abusada NJ. Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency. Scandinavian Journal of Infectious Diseases. 2008;40(11–12):983–5.
7.
Hanna RM, Sun SF, Gaynor P. A Case of Ertapenem Neurotoxicity Resulting in Vocal Tremor and Altered Mentation in a Dialysis Dependent Liver Transplant Patient. Antibiotics. 8(1):1.
8.
El Nekidy WS, Elrefaei H, St. John TJL, Attallah NM, Kablaoui F, Nusair A, et al. Ertapenem Neurotoxicity in Hemodialysis Patients—Safe and Effective Dosing Is Still Needed: A Retrospective Study and Literature Review. Annals of Pharmacotherapy. 2021;55(1):52–8.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
